These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 16678831)

  • 1. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
    Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
    Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
    Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit.
    Onat A; Ozhan H; Esen AM; Albayrak S; Karabulut A; Can G; Hergenç G
    Atherosclerosis; 2007 Aug; 193(2):380-8. PubMed ID: 16926017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
    Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
    Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
    Onat A; Can G; Hergenç G
    Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
    Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
    Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition].
    Onat A; Hergenç G; Can G
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):29-34. PubMed ID: 17347072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
    Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
    Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
    Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
    Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
    Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
    Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
    Onat A; Ozhan H; Erbilen E; Albayrak S; Küçükdurmaz Z; Can G; Keleş I; Hergenç G
    Int J Cardiol; 2009 Jun; 135(2):211-7. PubMed ID: 18582961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.
    Onat A; Avci GS; Barlan MM; Uyarel H; Uzunlar B; Sansoy V
    Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1018-25. PubMed ID: 15197408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance.
    Onat A; Hergenç G; Uyarel H; Yazici M; Tuncer M; Doğan Y; Can G; Rasche K
    Sleep Breath; 2007 Mar; 11(1):23-30. PubMed ID: 17061139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
    Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
    Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.
    Chou HH; Hsu LA; Liu CJ; Teng MS; Wu S; Ko YL
    Metabolism; 2010 Jun; 59(6):824-30. PubMed ID: 20004425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein is elevated in obese patients with the metabolic syndrome.
    Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
    Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.